New diabetes clinical trial: A Study of LY3209590 in Participants With Type 1 Diabetes

Published on: June 29, 2020 at 09:30PM
Condition:   Type 1 Diabetes Mellitus
Interventions:   Drug: LY3209590;   Drug: Insulin Degludec
Sponsor:   Eli Lilly and Company
Not yet recruiting
https://ift.tt/3i9Vj3T